BioCatalystWatch
SLNWorkspace / SLN / OverviewCompany library
Silence Therapeutics plc logo

Silence Therapeutics plc

Silence Therapeutics plc (SLN)

Website

Price
Market cap
Next catalystDec 14, 2026Divesiran — SANRECO Phase 1/2 · Phase 2 dataCompany presentation ↗
Cash

Chart & Events

Candle interval

Core Clinical

SLN365

GPR146

PreINDP1P2P3FilingApproved
SLN098

INHBE

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

TMPRSS6

PreINDP1P2FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

TMPRSS6

PreINDP1P2FilingApproved
Upcoming / outlook

SLN098

INHBE

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

SLN365

GPR146

PreINDP1P2P3FilingApproved

Other pipelines

divesiran (SLN124)

TMPRSS6

PreINDP1P2P3FilingApproved
zerlasiran (SLN360)

LPA

PreINDP1P2P3FilingApproved

Partner / License out

ANGPTL3

PreINDP1P2P3FilingApproved

History / paused

divesiran (SLN124)

TMPRSS6

PreINDP1P2P3FilingApproved

CFB

PreINDP1P2P3FilingApproved

p53

PreINDP1P2P3FilingApproved

C3

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Operating
Investing
Financing

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

SLN PR & News

PR & News

SLN SEC archive